Enveric Biosciences, Inc. (NASDAQ:ENVB) filed a Form 8-K with the Securities and Exchange Commission on January 28, 2026, disclosing a material event.
Enveric Biosciences, Inc.'s stock currently trades at $3.49 with a market capitalization of $3.2M. The Healthcare company's stock moved following the disclosure.